Pixium Vision announces its financial results as of June 30 2020 and provides business update

Pixium Vision announces its financial results
as of June 30 2020 and provides business update

Paris, July  23^rd 2020 - 6.00 p.m. CET – Pixium Vision (Euronext Growth Paris - FR0011950641 - ALPIX), a company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, announces its financial results for the first half of 2020, as approved by the Board of Directors on July 23^rd, 2020. The Half-Year Financial Report is available on the Group’s website.

Income statement summary
In thousands euros		H1 2020	H1 2019
Operating revenue		1,250.7	1,055.7
Operating expenses		(4,524.4)	(6,130.3)
Research and development		(2,860.1)	(3,879.6)
General and administrative expenses		(1,664.3)	(1,588.8)
Sales and marketing expenses		-	(11.0)
Current operating income		(3,273.7)	(4,423.7)
Non-recurring items		-	(650.9)
Operating income		(3,273.7)	(5,074.5)
Net result		(3,802.3)	(5,586.7)
Net earnings per share		(0.15)	(0.26)

Statement of cash flows summary
In thousands euros	H1 2020	H1 2019
Opening cash and cash equivalents	6,791.5	15,629.4
(Decrease)/Increase in cash position	(1,787.1)	(5,409.4)
O/W net cash flows from operating activities	(2,787.8)	(5,071.2)
O/W net cash flows from investment activities	163.7	(15.3)
O/W net cash flows from financing activities	837.0	(322.9)
Closing cash and cash equivalents	5,004.4	10,220.0